Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by BuddyGuyManon Jun 09, 2018 12:14pm
140 Views
Post# 28149892

RE:Interesting Articles

RE:Interesting ArticlesCan’t wait for the market to see the true value here. In the meantime I’m happy to keep buying while the price is low.  I’ve been slowly taking profit in a few other plays and moving them here.  Personally I see a short term double in share price.  Of course, the longer term picture will depend on execution of plans, and other future deals and unknowns.  But with 200,000kg annual production, plus their other investments, it’s fairly realistic to expect a 10X multiple from here.  The hard part will be holding on long term through spikes and volatility.  Good luck all. 


HempDude001 wrote: This one.
https://seekingalpha.com/article/4180265-legalization-marijuana-canada-true-potential-canopy-growth
and this one
https://business.financialpost.com/commodities/agriculture/canopy-growth-more-than-doubles-third-quarter-revenue-compared-with-year-ago

Canopy Growth (WEED) Growing capacity now. (To be expanded)
Tweed’s Commercial License for its facility in Smiths Falls, Ontario will be up for renewal on July 20, 2018. Tweed’s license to sell cannabis extracts was granted February 23, 2016 and was renewed on January 13, 2017. The license will be up for renewal again on July 13, 2018. Tweed’s Commercial License covers 168,000 square feet of its Smiths Falls facility. The license was amended to allow the production and sale of 6,000 kilograms of dried cannabis, reflecting Tweed’s present built-out production capacity of 12 climate controlled indoor growing rooms. Tweed has completed 12 of an eventual 39 growing rooms (of similar size), and the related vegetation, nutrient delivery and production infrastructure as is required to support the planned for 39 room configuration. Additionally, an in-house laboratory and R&D area, cannabis oil extraction infrastructure and a high-level security vault exist in the Smiths Falls facility as well. With all 39 equivalent rooms in production, it is estimated that the current space at Tweed’s Smiths Falls facility can support the production of approximately 11,000 kilograms per year.

In comparison FSD Pharma

Closed the purchase of the former Kraft food manufacturing facility in Cobourg, Ont., which is owned with no debt. The facility is an existing 620,000-square-foot indoor facility sitting on a 70-acre parcel of land with 40 acres primed for development. 
  • Strategic partnership through a joint venture agreement with Cannabis Wheaton Income Corp., whereby Wheaton will develop all aspects of the company's cultivation facility in mutually agreed staged phases to create the largest indoor cultivation and processing facility in the world. Wheaton will receive 49.9 per cent of all cannabis and cannabis-related production from the facility, in perpetuity. It is anticipated that at full capacity this will result in FV receiving approximately 200 million grams of dried cannabis flower per annum. The facility is expected to be an aggregate of approximately 3.8 million square feet at full capacity.
  • High-Tide: a fully integrated retail distribution company that has applied for 31 retail cannabis permits across Canada and owns four prominent brands: RGR Canada Inc, Smokers Corner, Canna Cabana and subject to shareholder approval, may obtain Famous Brandz;
  • Cannara Biotech Inc.: FSD currently owns 25 per cent. Cannara plans to be the largest indoor cultivation facility in Quebec that wholly owns a 625,000-square-foot indoor cultivation facility on 32 acres of land strategically positioned one hour north of Montreal, Que.;

I would say HUGE is setting up nicely.


Bullboard Posts